Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > ARISTOTLE is better than GRAIL to detect early cancers
View:
Post by Photoman77 on Sep 14, 2021 3:23pm

ARISTOTLE is better than GRAIL to detect early cancers

https://news.harvard.edu/gazette/story/2020/03/in-clinical-study-blood-test-can-detect-range-of-cancers/ 

"In a study involving thousands of participants, a new blood test (Grail) detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute, a Harvard affiliate, and the Mayo Clinic."

Here is the problem ^^


39 percent sensitivity for patients with stage I cancer
69 percent sensitivity for those with stage II cancer
83 percent sensitivity for those with stage III cancer
92 percent sensitivity for those with stage IV cacner

39% stage 1 is terrible for Grail! That's worse that a grade F in school.

Aristotle is far superior with over 90% accuracy at this stage for most common cancers

Grail for 8 billion dolalrs lol!
Comment by 4real4ever on Sep 14, 2021 7:20pm
**From Tripp's statement** **And your article has 1 1/2 year old. This kind on CEO make BIG progress in 1 1/2 year instead of others**
Comment by davewho on Sep 14, 2021 8:14pm
LONDON, Sept 13 (Reuters) - Britain's state-run National Health Service will on Monday begin the world's biggest trial of Grail Inc's (GRAL.O) flagship Galleri blood test that can be used to detect more than 50 types of cancer before symptoms appear. ie the Doc says you have 6 months to live. "We need to study the Galleri test carefully to find out whether it can ...more  
Comment by Nailbiter1 on Sep 14, 2021 9:30pm
This post has been removed in accordance with Community Policy
Comment by Teddy3 on Sep 14, 2021 10:12pm
Yea, SZLS has the best most accurate revolutionary cancer test because Tripp said so...LOLOOL! You can't be serious....can you? Why is volume at zero if so? Where is all the published data to proove so? Why wouldn't a larger company swoop in and buy SZLS for peanuts compared to the potential return if so? THEY HAVE NOTHING OF VALUE, ARE YOU PEOPLE CRAZY OR ALL JUST EMPLOYEES? Every ...more  
Comment by Teddy3 on Sep 14, 2021 10:14pm
Smart people who could actually read scientific papers and have inside knowledge of cancer and blood testing would be buying large amounts of this stock for cheap if so, trust me.
Comment by Teddy3 on Sep 14, 2021 10:15pm
And if for some reason I am wrong and SZLS does have a great product but still can't sell it or generate any interest, let that be an indictment on Tripp ability to lead a company.
Comment by LithLover on Sep 14, 2021 11:08pm
Ahhh I think they did.  The executives at Health Clinics accepted 12 million shares for their company despite even a short term drop in the share price.  And they made sure to note that if a buyout occurs the milestone payment is at $2.00 a share  Executives in the oncology field holding many patents.  I think they can read a scientific paper. But hey I'll take your ...more  
Comment by Teddy3 on Sep 15, 2021 8:55am
If all SZLS could find was a par of very small unknown Health Clinincs making very little money with a product you all claim is better than GRAIL is dead give away. The market literally acted like nothing happened when the deal closed. Nobody in reality thinks this will work of they have anything if value except the SZLS employees. The market does not lie. Look at the SP and volume and tell me ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities